Skip to main content
Log in

Comparison of the safety and efficacy of Nanostim and Micra transcatheter leadless pacemaker (LP) extractions: a multicenter experience

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

Leadless pacemaker (LP) extraction is a relatively new field with limited operator experience. We sought to report a comparison of retrieval process for Nanostim vs Micra transcatheter LPs.

Methods

The list of retrievals for the Micra transcatheter pacemaker system (TPS) was obtained from Medtronic whereas Nanostim data was obtained from centers that participated in the Leadless II study. Details of retrieval such as indication, days post implantation, complications, and post procedure device management were obtained from the manufacturer database for each site, and any missing details were obtained from individual operators. Extractions performed on the same day were labeled as “Early” and thereafter were labeled as “Late.”

Results

A total of 113 retrievals were attempted (73 in Nanostim and 40 in Micra TPS). The most common reasons for retrieval were battery advisory and inadequate pacing threshold (n = 16) for Nanostim and Micra, respectively. Success rate in Nanostim group was around 90% (66/73) compared with 100% in Micra group (p = 0.049). Late retrieval occurred in 50% of Micra TPS cases (20/40) compared with 100% of Nanostim LP cases. Median time to extraction was 46 days for Micra TPS and 256 days for Nanostim LP (p < 0.001). Rate of serious adverse events with Nanostim extraction was 3% (n = 2/73).

Conclusion

Overall, LP extraction is feasible and safe to perform irrespective of the duration and type of the device.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Knops RE, Tjong FV, Neuzil P, et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. J Am Coll Cardiol. Apr 21 2015;65:1497–504.

    Article  Google Scholar 

  2. Roberts PR, Clementy N, Al Samadi F, et al. A leadless pacemaker in the real-world setting: the Micra transcatheter pacing system post-approval registry. Heart rhythm Sep. 2017;14:1375–9.

    Article  Google Scholar 

  3. Ritter P, Duray GZ, Zhang S, et al. Micra transcatheter pacing study G. the rationale and design of the Micra transcatheter pacing study: safety and efficacy of a novel miniaturized pacemaker. Europace May. 2015;17:807–13.

    Article  Google Scholar 

  4. Koruth JS, Rippy MK, Khairkhahan A, et al. Percutaneous retrieval of implanted leadless pacemakers: feasibility at 2.5 years post-implantation in an in vivo ovine model. JACC: Clinical Electrophysiology 2015/12/01/ 2015;1:563–570.

  5. Lakkireddy D, Knops R, Atwater B, et al. A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. Heart rhythm Dec. 2017;14:1756–63.

    Article  Google Scholar 

  6. Reddy VY, Miller MA, Knops RE, et al. Retrieval of the leadless cardiac pacemaker: a multicenter experience. Circ Arrhythm Electrophysiol Dec. 2016;9.

  7. Afzal MR, Daoud EG, Cunnane R, et al. Techniques for successful early retrieval of the micra transcatheter pacing system: a worldwide experience. Heart rhythm Feb 7 2018.

Download references

Acknowledgments

We thank the following clinician scientists for their work:

Vivek Y. Reddy MD1

Icahn School of Medicine at Mount Sinai, New York, USA

3Homolka Hospital, Prague, Czech Republic

Marc A. Miller MD1

Icahn School of Medicine at Mount Sinai, New York, USA

Reinoud E. Knops MD2

Amsterdam Medical Center, Amsterdam, The Netherlands

Petr Neuzil MD PhD3

Prague, Czech Republic

Pascal Defaye MD4,

CHU, Grenoble, France;

Werner Jung MD5

Schwarzwald Baar Klinikum, Villingen-Schwenningen, Germany

Rahul Doshi MD6

USC University Hospital, Los Angeles, USA

Mark Castellani MD7

Sparrow Research, Lansing, USA

Adam Strickberger MD8

Inova Fairfax Hospital, Fairfax, USA

Hardwin R. Mead MD9

Sequoia Hospital, Redwood City, USA

Harish Doppalapudi MD10

University of Alabama, Birmingham, USA

Dhanunjaya Lakkireddy MD11

University of Kansas Medical Center

Matthew Bennett MD12

Vancouver General Hospital, Vancouver, Canada

Srinivas Dukkipati MD1

Icahn School of Medicine at Mount Sinai, New York, USA

Johannes Sperzel MD13

Hospital Kerckhoff Klinik, Bad Nauheim, Germany

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dhanunjaya Lakkireddy.

Ethics declarations

Conflict of interest

DL is a consultant to Johnson & Johnson, Abbott, Biotronik, Pfizer, and Boston Sci. RG is a consultant/speaker of Abbott Medical, Boston Scientific, Zoll Medical, Pfizer, Bristol Myers Squibb and a physician advisor of HealthTrust PG, Abiomed.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dar, T., Akella, K., Murtaza, G. et al. Comparison of the safety and efficacy of Nanostim and Micra transcatheter leadless pacemaker (LP) extractions: a multicenter experience. J Interv Card Electrophysiol 57, 133–140 (2020). https://doi.org/10.1007/s10840-019-00684-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-019-00684-y

Keywords

Navigation